BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26005675)

  • 1. Sirtuin 1 signaling and alcoholic fatty liver disease.
    You M; Jogasuria A; Taylor C; Wu J
    Hepatobiliary Surg Nutr; 2015 Apr; 4(2):88-100. PubMed ID: 26005675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of silent information regulator 1-serine/arginine-rich splicing factor 10-lipin 1 axis in the pathogenesis of alcohol fatty liver disease.
    Li Y; Zhou J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1117-1125. PubMed ID: 28467182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
    You M; Jogasuria A; Lee K; Wu J; Zhang Y; Lee YK; Sadana P
    Curr Mol Pharmacol; 2017; 10(3):226-236. PubMed ID: 26278388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin and alcoholic fatty liver disease.
    Rogers CQ; Ajmo JM; You M
    IUBMB Life; 2008 Dec; 60(12):790-7. PubMed ID: 18709650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipin-1 in the pathogenesis of alcoholic fatty liver.
    Bi L; Jiang Z; Zhou J
    Alcohol Alcohol; 2015 Mar; 50(2):146-51. PubMed ID: 25595739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
    Yin H; Hu M; Liang X; Ajmo JM; Li X; Bataller R; Odena G; Stevens SM; You M
    Gastroenterology; 2014 Mar; 146(3):801-11. PubMed ID: 24262277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease.
    Chen H; Shen F; Sherban A; Nocon A; Li Y; Wang H; Xu MJ; Rui X; Han J; Jiang B; Lee D; Li N; Keyhani-Nejad F; Fan JG; Liu F; Kamat A; Musi N; Guarente L; Pacher P; Gao B; Zang M
    Hepatology; 2018 Aug; 68(2):496-514. PubMed ID: 29457836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate-Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease.
    Zhu L; Xu JJ; Li HD; Li JJ; Cheng M; Niu XN; Jia PC; Liu JY; Huang C; Lv XW; Li J
    Lab Invest; 2023 Apr; 103(4):100041. PubMed ID: 36870291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.
    You M; Liang X; Ajmo JM; Ness GC
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G892-8. PubMed ID: 18239056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adiponectin-SIRT1-AMPK pathway in alcoholic fatty liver disease in the rat.
    Jiang Z; Zhou J; Zhou D; Zhu Z; Sun L; Nanji AA
    Alcohol Clin Exp Res; 2015 Mar; 39(3):424-33. PubMed ID: 25703252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptotanshinone from the
    Nagappan A; Kim JH; Jung DY; Jung MH
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Roles of SIRT1 in Alcoholic Liver Disease.
    Ren R; Wang Z; Wu M; Wang H
    Int J Biol Sci; 2020; 16(16):3174-3183. PubMed ID: 33162823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin: a key adipokine in alcoholic fatty liver.
    You M; Rogers CQ
    Exp Biol Med (Maywood); 2009 Aug; 234(8):850-9. PubMed ID: 19491377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.
    Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B
    Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1/AMPK signaling pathway.
    Bai T; Yang Y; Yao YL; Sun P; Lian LH; Wu YL; Nan JX
    Pharmacol Res; 2016 Mar; 105():1-12. PubMed ID: 26776965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.